Science and innovation

Check out our news

Get our newsletters

Published on the 6 February 2023

New cardiovascular model available at SYNCROSOME

Collaboration with VASA Therapeutics : characterization a heart failure model with preserved ejection fraction (HFpEF) / Dahl salt sensitive rats. Download all informations (pdf) Financial Disclosur…

Science and innovation
Published on the 15 November 2022

SfN 2022 – Poster

Our team is very proud of its first PhD Student, Florent Lebrun.He presented great results from its research work during yesterday morning poster session at the Society for Neuroscience Congress 2022 …

Science and innovation Events
Published on the 4 November 2022

Society for Neuroscience annual congress in San Diego (USA) – 12th to 16th november.

Come meet Dr Nicolas Violle and Florent Lebrun at the Society for Neuroscience annual congress in San Diego (USA), 12th to 16th november. Florent Lebrun will share wit…

Science and innovation Events
Published on the 3 October 2022

NEWS for CNS Department

Nose-to-brain delivery allows application of drugs at the roof of the nasal cavity, which are transported to the central nervous system (CNS) of humans (A) and rodents (B). Nose-to-brain transport …

Science and innovation
Published on the 18 July 2022

NEWS for cardiovascular Department

SYNCROSOME has acquired a new Echocardiograph Vivid™ S60 , GE Healthcare Logiciel version : R3 Probes : 12S-D and linear probe L8-18i-D Vivid™ S60 is used to measure cardiac morph…

Science and innovation
Published on the 21 April 2022

New research article

A new research article resulting from a collaboration between the Institut de Cancérologie de Lorraine, bladder cancer company Photocure and ETAP-Lab was recently published in the journal Biomedicines…

Science and innovation
Published on the 24 March 2022

The ETAP-Lab poster presented at AD/PD 2022 is available online

The poster we presented at the Alzheimer’s Disease and Parkinson’s Disease conference is now available ; it’s all about our innovative in vitro and in vivo models of Alzheimer’s disease, which are bas…

Science and innovation
Published on the 8 March 2022

Neurology: Alpha-synuclein oligomers involved in Parkinson’s disease pathogenesis! New publication in the journal GLIA, highlighted by NATURE REVIEW Neurology

Dr. Ahmad Allouche (Head of In Vitro Biology at ETAP-Lab) is co-author of the article: “Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/…

Science and innovation

Explore our scientific resources and browse posters…

Explore Our Resources